Smith & Nephew SNATS ROE 2010-2023 | SNN
Smith & Nephew SNATS ROE - Return on Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Shareholder's Equity | Return on Equity |
2014-12-31 | $0.50B | $4.04B | 12.20% |
2014-09-30 | $0.50B | $4.02B | 12.24% |
2014-06-30 | $0.52B | $4.16B | 12.81% |
2014-03-31 | $0.56B | $4.22B | 14.01% |
2013-12-31 | $0.56B | $4.05B | 14.07% |
2013-09-30 | $0.54B | $3.91B | 13.71% |
2013-06-30 | $0.55B | $3.90B | 14.26% |
2013-03-31 | $0.71B | $3.95B | 18.91% |
2012-12-31 | $0.73B | $3.88B | 20.06% |
2012-09-30 | $0.73B | $3.64B | 21.01% |
2012-06-30 | $0.73B | $3.56B | 21.91% |
2012-03-31 | $0.59B | $3.45B | 18.30% |
2011-12-31 | $0.58B | $3.19B | 18.80% |
2011-09-30 | $0.62B | $3.06B | 20.86% |
2011-06-30 | $0.63B | $3.13B | 22.06% |
2011-03-31 | $0.61B | $3.00B | 23.17% |
2010-12-31 | $0.62B | $2.77B | 25.14% |
2010-09-30 | $0.56B | $2.48B | 24.41% |
2010-06-30 | $0.55B | $2.31B | 25.31% |
2010-03-31 | $0.53B | $2.23B | 25.71% |
2009-12-31 | $0.47B | $2.18B | 24.28% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $10.404B | $5.549B |
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $189.499B | 24.60 |
Stryker (SYK) | United States | $128.469B | 31.85 |
Medtronic (MDT) | Ireland | $105.230B | 14.90 |
Boston Scientific (BSX) | United States | $99.939B | 33.23 |
EssilorLuxottica (ESLOY) | France | $98.203B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $42.924B | 0.00 |
Haleon (HLN) | United Kingdom | $36.986B | 28.93 |
ResMed (RMD) | United States | $27.191B | 27.18 |
Terumo (TRUMY) | Japan | $25.327B | 35.77 |
Zimmer Biomet Holdings (ZBH) | United States | $25.081B | 16.15 |
Baxter (BAX) | United States | $20.095B | 14.66 |
Koninklijke Philips (PHG) | Netherlands | $18.879B | 15.06 |
Insulet (PODD) | United States | $12.094B | 63.50 |
Demant (WILYY) | Denmark | $10.151B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.349B | 24.87 |
BellRing Brands (BRBR) | United States | $7.231B | 38.88 |
Haemonetics (HAE) | United States | $4.275B | 21.86 |
Lantheus Holdings (LNTH) | United States | $4.232B | 10.93 |
Perrigo (PRGO) | Ireland | $4.060B | 11.61 |
GN Store Nord (GNNDY) | Denmark | $3.675B | 23.80 |
Envista Holdings (NVST) | United States | $3.399B | 12.93 |
Prestige Consumer Healthcare (PBH) | United States | $3.379B | 15.98 |
QuidelOrtho (QDEL) | United States | $2.695B | 9.78 |
Neogen (NEOG) | United States | $2.634B | 25.33 |
Green Thumb Industries (GTBIF) | United States | $2.613B | 82.80 |
ICU Medical (ICUI) | United States | $2.347B | 17.51 |
TG Therapeutics (TGTX) | United States | $2.162B | 700.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.046B | 0.00 |
Owens & Minor (OMI) | United States | $1.903B | 18.27 |
Verano Holdings (VRNOF) | United States | $1.686B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.618B | 0.00 |
InMode (INMD) | Israel | $1.480B | 7.66 |
National Vision Holdings (EYE) | United States | $1.479B | 46.05 |
LeMaitre Vascular (LMAT) | United States | $1.430B | 47.50 |
AdaptHealth (AHCO) | United States | $1.277B | 9.61 |
Warby Parker (WRBY) | United States | $1.241B | 0.00 |
AtriCure (ATRC) | United States | $1.117B | 0.00 |
MacroGenics (MGNX) | United States | $1.044B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.725B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.709B | 0.00 |
Evolus (EOLS) | United States | $0.698B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.698B | 15.07 |
Jin Medical (ZJYL) | China | $0.673B | 0.00 |
Canopy Growth (CGC) | Canada | $0.610B | 0.00 |
Quanterix (QTRX) | United States | $0.610B | 0.00 |
Valneva SE (VALN) | France | $0.556B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.526B | 11.40 |
TerrAscend (TSNDF) | Canada | $0.510B | 0.00 |
PetIQ (PETQ) | United States | $0.477B | 17.80 |
ZimVie (ZIMV) | United States | $0.427B | 26.15 |
Biote (BTMD) | United States | $0.426B | 4.05 |
OraSure Technologies (OSUR) | United States | $0.399B | 6.61 |
Zynex (ZYXI) | United States | $0.391B | 45.00 |
Surmodics (SRDX) | United States | $0.379B | 40.92 |
Aurora Cannabis (ACB) | Canada | $0.322B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.320B | 31.77 |
Cerus (CERS) | United States | $0.305B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.273B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.253B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.244B | 14.91 |
Omeros (OMER) | United States | $0.199B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.195B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.194B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.187B | 0.00 |
Veru (VERU) | United States | $0.184B | 0.00 |
High Tide (HITI) | Canada | $0.177B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
FitLife Brands (FTLF) | United States | $0.132B | 21.19 |
Jushi Holdings (JUSHF) | United States | $0.128B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.125B | 62.70 |
Allurion Technologies (ALUR) | United States | $0.113B | 0.00 |
InterCure (INCR) | Israel | $0.108B | 18.23 |
Cellectar Biosciences (CLRB) | United States | $0.107B | 0.00 |
Fonar (FONR) | United States | $0.106B | 9.12 |
Safety Shot (SHOT) | United States | $0.102B | 0.00 |
MariMed (MRMD) | United States | $0.102B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
Brainsway (BWAY) | Israel | $0.085B | 0.00 |
Chimerix (CMRX) | United States | $0.082B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.072B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.061B | 3.97 |
Apyx Medical (APYX) | United States | $0.048B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
Bright Green (BGXX) | United States | $0.041B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
United-Guardian (UG) | United States | $0.036B | 13.91 |
Modular Medical (MODD) | United States | $0.034B | 0.00 |
Exagen (XGN) | United States | $0.025B | 0.00 |
Nephros (NEPH) | United States | $0.021B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.020B | 0.00 |
Flora Growth (FLGC) | United States | $0.019B | 0.00 |
Agape ATP (ATPC) | $0.018B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 71.36 |
ProSomnus (OSA) | United States | $0.009B | 0.00 |
NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |